8
Mar 2026
A large longitudinal study of U.S. adults found that many older people improve in cognitive function or walking speed over time, challenging the idea that aging inevitably leads to decline. Positive beliefs about aging were associated with higher odds of improvement in both cognitive and physical health.
8
Mar 2026
Researchers reviewed how somatic mutations accumulate in normal and diseased tissues, showing that natural selection can expand clones that influence disease risk, tissue adaptation, or cellular resilience. The study proposes somatic genomics as a powerful strategy to uncover disease mechanisms and identify new therapeutic targets across multiple conditions.
8
Mar 2026
esearchers developed MedVersa, a generalist multimodal AI model trained on tens of millions of medical imaging instances to perform diverse radiology tasks within a single framework. The model matched or exceeded specialist AI systems across several benchmarks and produced radiology reports comparable to human reports in many cases while improving reporting efficiency.
6
Mar 2026
The University of Oklahoma's Native Nations Center for Tribal Policy Research recently released a new Sovereign Report titled "Purchased/Referred Care and Cancer: Overview and Options for Tribal Consideration."
6
Mar 2026
Researchers at the University of Colorado Anschutz have identified a critical gap in how post-amputation pain is evaluated and treated.
6
Mar 2026
GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs were later found to promote weight loss and improve cardiovascular health.
6
Mar 2026
A new case report was published in Volume 13 of Oncoscienceon February 7, 2026, titled "Massive calcified solid pseudopapillary neoplasm of the pancreatic head."
6
Mar 2026
Psilocybin - the psychoactive compound in "magic mushrooms" - is gaining scientific attention for its potential in treating neuropsychiatric conditions including depression, anxiety, substance use disorders and certain neurodegenerative diseases.
6
Mar 2026
Researchers at Baylor College of Medicine have discovered a potential new strategy to fight back against Alzheimer's and Parkinson's diseases, conditions that are linked to the toxic accumulation of Tau and alpha synuclein protein clumps in the brain.
6
Mar 2026
A naturally occurring byproduct of liver metabolism–the ketone body, β-hydroxybutyrate (BHB)–can strengthen the fitness and antitumor activity of CAR T cells.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
